Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6199199 | Ophthalmology | 2016 | 9 Pages |
Abstract
It is feasible to place a long-acting FAi in an outpatient setting, without prolonged adverse events attributed to the implant injection procedure. The FAi effectively controlled intraocular inflammation in all eyes in the study, and at the last follow-up, all implanted eyes demonstrated an improvement in visual acuity. Elevated IOP that occurred in 18% of FAi-implanted eyes was managed by standard means. The FAi implant is a promising approach for patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis who do not respond to, or are intolerant to, conventional therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Glenn J. MD, Phoebe MD, PhD, Robert T. MD, MPH, Paul PhD, Cindy RN, COT, Sandra S. DrPH,